Sergio Fragoso-Saavedra, Isaac Núñez, Belem M. Audelo-Cruz, Sarahi Arias-Martínez, Daniel Manzur-Sandoval, Alejandro Quintero-Villegas, . . . Sergio Iván Valdés-Ferrer. (2022). Pyridostigmine reduces mortality of patients with severe SARS-CoV-2 infection: A phase 2/3 randomized controlled trial. BMC.
Chicago Style (17th ed.) CitationSergio Fragoso-Saavedra, et al. Pyridostigmine Reduces Mortality of Patients with Severe SARS-CoV-2 Infection: A Phase 2/3 Randomized Controlled Trial. BMC, 2022.
MLA (9th ed.) CitationSergio Fragoso-Saavedra, et al. Pyridostigmine Reduces Mortality of Patients with Severe SARS-CoV-2 Infection: A Phase 2/3 Randomized Controlled Trial. BMC, 2022.
Warning: These citations may not always be 100% accurate.